Hahnemann Laboratories, Inc
FTC to Host September Workshop in Washington, DC, to Examine Advertising for Over-the-Counter Homeopathic Products
Hahnemann Laboratories' Response to FTC Regarding Advertising for Over-the-Counter Homeopathic Products 11/12/15 We are fortunate to say that in our 30 years of business as a pharmaceutical manufacturer, Hahnemann Laboratories, Inc. did not have a single Adverse Drug Event to report. The National Poison Data System (NPDS), Table 22B documented Homeopathy with just 1(one) "major event" and not a single death compared to the allopathic industry documenting 117,752 deaths in just 2013. According to the American Medical College of Homeopathy (AMCH) "Nearly three hundred studies have been conducted, studying a variety of conditions, with positive results for homeopathy demonstrated in about 85% of the studies", and ClinicalTrials.gov alone lists 82 studies in Homeopathy as of April 2015. Just to mention a few: - Homeopathy in Pediatric Oncology in Germany - Immunology and Homeopathy - Evidence-Based Research on the Nanoparticle Nature of Homeopathic Medicines - Depression in Peri- and Postmenopausal Women - Anti-Anxiety properties of homeopathic Gelsemium Hahnemann Labs products were used in five randomized, double-blind, placebo-controlled clinical studies on homeopathic Arnica Montana for surgical applications in Liposuction, Facelift and Rhinoplasty. How can most panelists of the Federal Trade Commission ignore cutting edge scientific research on the nanoparticle medicine of Homeopathy? Many panelists who were not well informed dispersed unfounded opinions, while degrading Homeopathy in the public eye, when millions of customers around the globe already benefit from homeopathic treatment, where conventional drugs have failed or resulted in too many harmful side effects. Please refer to the attached research results and hard data showing safety and efficacy of Homeopathic product (Response to FDA: Homeopathic Product Regulation) Based on our 30 years of extensive experience with homeopathic pharmaceuticals, Hahnemann Labs, Inc. considers the existing FDA regulations sufficient for the sake of safety and efficacy to the General Public Health. Thank you for your considerations, Helga Alessio, VP QA Hahnemann Laboratories, Inc.